Investigation of mitochondrial common deletion and BRCA mutations for detection familial breast cancers in archival breast cancer materials

Iranian Journal of Cancer Prevention

Volumn 2, Issue 2, 2009, Pages 77-83

  Rassi, H ^a   Houshmand, Massoud ^a   Hashemi, M ^b   Majidzadeh, A K ^d   Hosseini Akbari, M H ^c  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Baghiatollah Hospital   (Iran)

^d Iranian Center for Breast Cancer   (Iran)

Author keywords

Archival breast cancer tissues; Breast cancer; Multiplex PCR; Mutation detection; nDNA and mtDNA mutations; Retrospective clinical studies

Indexed keywords

BRCA1 PROTEIN; MITOCHONDRIAL DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; BREAST CANCER; CANCER GRADING; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; EARLY DIAGNOSIS; FAMILIAL CANCER; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; MITOSIS; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PREVALENCE; RISK FACTOR;

EID: 77953367456     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
2. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997; 71: 800-9.
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Lui Q,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
4. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N,et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92.
5. An Open Access Online Breast Cancer Mutation Database. Bethesda (MD): National Human Genome Research Institute; 2002. Available from: http://www.nhgri.nih.gov.
6. Kang D, Hamasaki N. Mitochondrial disease: maintenance of mitochondrial genome and molecular diagnostics. Adv Clin Chem. 2006; 42: 217-54.
7. Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 2005; 26: 145-52.
8. Kamalidehghan B, Houshmand M, Panahi MS, Abbaszadegan MR, Ismail P, Shiroudi MB. Tumoral cell mtDNA approximately 8.9 kb deletion is more common than other deletions in gastric cancer. Arch Med Res. 2006;37(7):848-53.
9. Rassi H, Houshmand M. Diagnostic algorithm for identification of individuals with hereditary predisposition to breast cancer. Lik Sprava. 2008; Jan-Feb;(1-2):103-8.
10. Farshid G, Balleine RL, Cummings M, Waring P; Cuningham K. Consortium for Research into Familial Breast Cancer (kConFab). Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol. 2006; 30: 1357-66.
11. Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM,et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl. Cancer Inst 1998; 90: 1138-45.
12. Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D,et al. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin. Cancer Res 2000; 6: 782-9.
13. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002; 20: 2310-8.
14. Wu L, Patten N, Yamashiro CT, Chui B. Extraction and amplification of DNA from formalin-fixed, paraffin-embedded tissues. Appl Immunohistochem Mol Morphol.2002; 10:269-74.
15. Shi SR, Datar R, Liu C, Wu L, Zhang Z, Cote RJ, Taylor CR. DNA extraction from archival formalin-fixed, paraffin-embedded tissues: heat-induced retrieval in alkaline solution. Histochem Cell Biol. 2004; 122:211-8.
16. Chan PC, Wong BY, Ozcelik H, Cole DE. Simple and Rapid Detection of BRCA1 and BRCA2 Mutations by Multiplex Mutagenically Separated PCR. Clinical Chemistry.1999; 45: 1285-7.
17. Zullo, S.J. In situ PCR of the common human mitochondrial DNA deletion: Is it related to apoptosis? Chapter 6. In: Mitochondrial DNA: Methods and Protocols (Copeland, W.C., ed.). Humana Press 2002, Clifton, NJ, USA
18. Inoue T, Nabeshima K, Kataoka H, Koono M. Feasibility of archival non-buffered formalin-fixed and paraffin-embedded tissues for PCR amplification: an analysis of resected gastric carcinoma. Pathol Int. 1996; 46: 997-1004.
19. Cooper M, Li SQ, Bhardwaj T, Rohan T, Kandel RA. Evaluation of oligonucleotide arrays for sequencing of the p53 gene in DNA from formalin-fixed, paraffin-embedded breast cancer specimens. Clin Chem. 2004; 50:500-8.
20. Bernstein JL, Thompson WD, Casey G, DiCioccio RA, Whittemore AS, Diep AT, Thakore SS,et al. Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue. Cancer Epidemiol Biomarkers Prev. 2002; 11:809-14.
21. Ellis IO, Coleman D, Wells C, Kodikara S, Paish EM, Moss S, Al-Sam S, et al. Impact of a national external quality assessment scheme for breast pathology in the UK. J Clin Pathol. 2006; 59: 138-45.
22. Coombs NJ, Gough AC, Primrose JN. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res. 1999 Aug 15;27(16):e12.
23. Dovzhenko SP, Rassi Kh, Zakhartseva LM, Podol'skaia SV, Miasoedov DV, Gorovenko NG. Several risk factors of breast cancer development and prognosis of the course of the disease in patients from Ukraine. Lik Sprava. 2007 Oct-Nov;(7):80-2.